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A purified preparation of a major allergen of Japanese cedar pollen, sugi basic protein @BP, Cry j I), was separated 
into 5 subfractions of 5&45 kDa. All of the SBP subfractions were confirmed to be reactive to IgE antibodies from pa- 
tients with Japanese cedar pollinosis, and also to mouse anti-SBP monoclonal antibodies. The sequences of 20 N-terminal 
amino acids of these 5 subfractions were found to be identical. Peptide mapping analyses of the SBP subfractions showed 
similar patterns, with some differences which might in part be due to the existence of an N-linked carbohydrate chain. 
The N-terminal amino acid sequence of SBP was identical to the reported sequence of an allergen of mountain cedar 
which vegetated in North America. 
Sugi basic protein; N-terminal amino acid sequence 
1. INTRODUCTION 
Plant pollens are the most common causes of 
seasonal allergic disease. In Japan, the number of 
patients suffering from Japanese cedar (Crup- 
torneria japonica) pollinosis is steadily increasing, 
and this has become a serious social problem. 
Yasueda et al. [l] have reported that the purified 
sugi basic protein (SBP; Cry j I [2]), a major 
allergen from Japanese cedar pollen, could be 
separated into 4 subfractions on the bases of 
molecular mass and isoelectric point. However, 
these 4 subfractions were shown to have identical 
antigenicity and allergenicity to each other in im- 
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munodiffusion analyses and in intradermal skin 
tests as well as RAST. Recently, in clinical and im- 
munological studies on French and Japanese pa- 
tients allergic to pollen of cypress and Japanese 
cedar, respectively, Panzani et al. [3] reported that 
a clear cross-reactivity was observed between the 
allergens derived from these two pollens. 
However, the amino acid sequences of SBP and 
cypress allergen have not been determined. Infor- 
mation on the primary structures of these allergens 
should be useful for estimation of the cross- 
reactivity of the allergens, and of further value in 
standardization of the allergens, as well as for 
diagnosis and treatment of the patients. Here, to 
analyze the amino acid sequence of SBP, further 
purification of the allergen was performed. Five 
subfractions of SBP were separated and purified to 
homogeneity. N-terminal amino acid sequences of 
the 5 subfractions were determined to be identical 
through 20 cycles. The N-terminal 5 amino acid 
residues of SBP were found to be identical with 
those of mountain cedar allergen reported by 
Gross et al. [4]. 
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2. MATERIALS AND METHODS 
SBP was purified from Japanese cedar pollen according to 
Yasueda et al. [I] with the slight modification of using Cetavlon 
(hexadecyltrimethylammonium bromide, Sigma) to remove 
polysaccharides. The SBP obtained was further purified as 
described in the text. The Mono S column, TSK gel G2000 SW 
column, RP-304 and RP-318 column were purchased from 
Pharmacia (Sweden), Toyo-Soda (Tokyo) and Bio-Rad (CA, 
USA), respectively. 
Mouse anti-SBP Mabs were prepared in our laboratory [5]. 
Peroxidase-labeled rabbit anti-mouse immunoglobulins were 
purchased from Dakopatts (Denmark). Fluorometric ELISA 
for IgE antibody assay was performed as in 161. 
N-terminal amino acid sequencing was performed by 
automated Edman degradation with an Applied Biosystems 
470A sequencer (Applied Biosystems, CA, USA). 
Peptide mapping analyses were performed as follows: SBP or 
SBP subfraction was incubated in boiling water for 10 min, and 
then digested with 1% lysylendopeptidase (Wake) at 37°C for 
16 h. Without incubation in boiling water, SBP or its subfrac- 
tions could not be digested by this enzyme. After digestion, 
each sample was fractionated on an RP-318 HPLC column with 
a linear gradient of O-50% acetonitrile/O. 1% TFA. The amino 
acid sequences of some peptides were then analyzed. 
3. RESULTS AND DISCUSSION 
Further purification of SBP using the Mono-S 
FPLC column equilibrated with 20 mM Tris-HCl 
buffer, pH 7.8, revealed that SBP was separated 
into 5 peaks of subfractions with a linear gradient 
of 25-100 mM Tris-HCl, pH 7.0 (fig.la). All 5 
peaks of the subfractions were confirmed to be 
reactive to mouse anti-SBP Mab. Each of the 5 
peaks was subjected to rechromatography with 
Mono-S column under the same conditions. The 5 
subfractions obtained, termed Frl-Fr5, were fur- 
ther purified to homogeneity in SDS-PAGE 
analyses using a TSK gel G2000 SW HPLC col- 
umn. As shown in fig.lb, original SBP showed 
multiple protein bands of 50-45 and 37 kDa, 
whereas each of the 5 subfractions showed a single 
band at 50-45 kDa. None of the subfractions 
showed a band corresponding to the 37 kDa pro- 
tein of original SBP. 
The allergenicities of the 5 subfractions obtained 
were ascertained by fluorometric IgE-ELISA using 
sera from 9 patients with Japanese cedar pollinosis 
and P-D-galactosidase-labeled anti-human IgE an- 
tibodies. Original SBP, crude extract (CE) of the 
pollen and nonallergic volunteer’s sera were used 
as controls. Table 1 lists the results. All of the 9 
sera from patients reacted strongly with all 5 sub- 
fractions as well as with original SBP and CE. 
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Fig.1. Separation of SBP subfractions. (a) Mono S column 
chromatogram of SBP. Each of the 5 peaks (Frl-Fr5) was 
collected separately at a flow rate of 0.5 ml/min, and subjected 
to further purification. (b) SDS-PAGE (12.5%) of SBP and 
purified subfractions. SDS-PAGE was performed under 
nonreducing conditions. The gel was stained with Coomassie 
brilliant blue. 
Each subfraction showed a very similar profile of 
reactivities vs the 9 sera. The results indicate that 
all of the 5 subfractions obtained as described 
above have some of the allergenicities of original 
SBP. 
Each of the 5 purified subfractions was desalted 
using an RP-304 HPLC column with a linear gra- 
dient of O-90% acetonitrile in 0.1% TFA, and the 
N-terminal amino acid sequence analyzed. As 
shown in table 2, the 5 subfractions showed iden- 
tical N-terminal sequences beginning with Asp 
through 20 cycles. We therefore attempted to 
determine the N-terminal sequence of the original 
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Table 1 
Allergenicities of SBP subfractions 
Allergens Proteina 
concentra- 
tion 
Cug/ml) 
Patient no. Nonallergic 
1 2 3 4 5 6 I 8 9 10 11 
Crude extract 10 3124b 3413 2281 1960 1867 2768 2623 2646 3451 0 0 
SBP 1 3919 3941 2937 2464 2444 3197 3531 3267 3765 0 0 
SBP subfractions 
Frl 1 4514 4468 3453 2993 2769 3635 3855 3559 4368 0 0 
Fr2 1 4211 4242 3045 2617 2493 2476 3999 3401 4050 0 0 
Fr3 1 4189 4346 3121 2521 2586 3628 3624 3278 4043 0 0 
Fr4 1 4202 4218 2904 2525 2387 3535 3627 3255 3935 0 0 
Fr5 1 4292 4142 2997 2412 2402 3393 3691 3231 3978 0 0 
a For coating of the solid phase 
b Allergenicity was measured by fluorometric enzyme-linked immunosorbent assay [6] using allergic sera and P-D- 
galactosidase labeled rabbit anti-human 1gE. Results are expressed as fluorescence units 
Table 2 
N-terminal amino acid sequence analysis of SBP and SBP subfractions 
SBP subfractions 
1 10 20 
Frl NHz-Asp-Asn-Pro-Ile-Asp-Ser-?-Trp-Arg-GIy-Asp-Ser-Asn- ? -Ala-Gln-Asn- ? -Met-Lys- 
Fr2 NHa-Asp-Asn-Pro-lle-Asp-Ser-?- ? -Arg-Gly-Asp-Ser-Asn- ? -Ala-Gln-Asn-Arg-Met-Lys- 
Fr3 NH*-Asp-Asn-Pro-lle-Asp-Ser- ? ? - ? -Gly-Asp-Ser-Asn- ? -Ala-Gln- ? - ? -Met-Lys- - 
Fr4 NH*-Asp-Asn-Pro-lle-Asp-Ser-?-Trp- ? -Gly-Asp-Ser-Asn-Trp-Ala-Gln-Asn- ? -Met-Lys- 
Fr5 NH2-Asp-Asn-Pro-Ile-Asp-Ser-?-Trp-Arg-Gly-Asp-Ser-Asn-Trp-Ala-Gln-Asn-Arg-Met-Lys- 
Original SBP 
NH~-Asp-Asn-Pro-Ile-Asp-Ser-?-Trp-Arg-Gly-Asp-Ser-Asn-Trp-Ala-Gln-Asn-Arg-Met-Lys- 
Mountain cedar pollen allergen [4] 
NHZ-Asp-Asn-Pro-Ile-Asp- 
?, not identified 
SBP. When desalted on an RP-304 HPLC column, 
the original SBP eluted in only one peak cor- 
responding to a protein of 50-45 kDa, and the 
37 kDa protein could not be eluted from the col- 
umn. From this, it was suggested that the 37 kDa 
protein of SBP was more hydrophobic than the 
50-45 kDa SBP subfractions. The N-terminal se- 
quence of original SBP was found to be identical 
with those of the 5 subfractions. Interestingly, the 
N-terminal 5 amino acid residues of SBP were 
found to be identical with those of mountain cedar 
allergen reported by Gross et al. [4]. Mountain 
cedar and cypress belong to the same family 
(Cupressaceae), so the cypress allergen might have 
some homology with SBP. The result does not con- 
flict with the results concerning the cross-reactivity 
between SBP and cypress pollen allergen reported 
by Panzani et al. [3]. Furthermore, we found that 
the SBP subfraction of 37 kDa protein has dif- 
ferent allergenicity and N-terminal amino acid se- 
quence from those of the 5 subfractions. Details 
will be presented elsewhere (in preparation). 
The 5 subfractions of SBP differ slightly in 
molecular mass. However, N-terminal sequence 
analyses revealed that they might be homologous 
protein. We thus performed peptide mapping 
analyses of the subfractions. Because of the 
availability of purified protein, only 3 subfractions 
(Fr3-Fr5) could be analyzed. The results are 
shown in fig.2. The elution patterns are similar. 
However, one of the differences apparently 
observed is that peptide L4 in Fr4, corresponding 
to L3 in Fr3 and L5 in Fr5, was eluted earlier, hav- 
ing a smaller retention time, than L3 and L5 (the 
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tW2-Glu-Ala-Phe-Am-Val-Glu-Am-Gly, 
Fr3 
NH2-Glu-Ala-Phe-Am-V 
Fr4 
sn-Ala-Thr-Pro-Gin-Leu-Thr-Lys-COOH 
Glu-Am-Gly-? -Ala-Thr-Pro Gln-Leu-l'hr-Lys-COOH 
I L4 
FrS 
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Fig.2. Lysylendopeptidase maps of SBP subfractions. Peptides of lysylendopeptidase-digested Fr3-Fr5 were separated on an RP-318 
HPLC column in 0.1% TFA with a linear gradient of O-50% acetonitrile containing 0.1% TFA in 90 min. The flow rate was 
0.5 ml/min. ?, not identified. 
latter 2 peptides eluted in exactly the same posi- 
tion). Amino acid sequence analyses of the 3 pep- 
tides revealed that they have the same amino acid 
sequence, but residue 9 of L4 could not be iden- 
tified, while residues 9 of L3 and L5 could be 
determined as Asn, suggesting that Asn in L4 was 
glycosylated but not Asn in L3 and LS. The results 
suggest that slight differences in molecular mass 
among the 5 subfractions might in part be due to 
the existence of an N-linked carbohydrate chain. 
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